Phase II evaluation of metoprine in advanced pancreatic adenocarcinoma

Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1053-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy*
  • Pyrimethamine / analogs & derivatives*
  • Pyrimethamine / therapeutic use

Substances

  • Antineoplastic Agents
  • metoprine
  • Pyrimethamine